'DMDC Bill will align India's regulatory system with global best regulatory practices' https://ift.tt/cd1eMWX

The Drugs, Medical Devices, and Cosmetics Bill, 2023 if made into a law, is expected to benefit patients in terms of expeditious access to new, safe, and quality therapies, informed Dr Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI)

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wFoSW53
Share:

Related Posts:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.